CNC Centene Corporation Common Stock
Centene Corporation Common Stock 정보 위키백과 회사 개요
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500.
더 보기
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500.
History
Centene was founded by Elizabeth Brinn as Managed Health Services in Milwaukee, Wisconsin, in 1984. After the death of Brinn, the non-profit organization was sold to investors. The proceeds went to the Betty Brinn Foundation, which became a major shareholder in Centene. In 1996, Michael Neidorff joined the company as chief executive.
Centene went public in December 2001. In 2006, the firm acquired US Script, a pharmacy benefits manager. The company later merged US Script with subsidiaries to form its Envolve divisions. In 2011, the firm formed Centurion, a provider of correctional health care services, as a joint venture with MHM Services. In 2018, it acquired MHM Services, including its stake in Centurion. Centene began offering state-run Medicaid programs through Affordable Care Act exchanges in 2014.
In July 2015, Centene announced it would acquire Health Net and Trillium Community Health Plan (serving Oregon). In March 2016, it finalized its acquisition. In September 2017, it announced that it would acquire Fidelis Care, a nonprofit insurer in New York, for US$3.75 billion. In March 2019, it announced plans to acquire WellCare for US$17.3 billion. In January 2021, it was announced that it would acquire Magellan Health for $2.2 billion. In January 2022, the acquisition was completed.
In the United Kingdom, Centene began to acquire local healthcare services in 2017. In 2019, Centene, through its subsidiary MH Services, took a 40% stake in Circle Health, as part of a deal which created a national network of over 50 private hospitals. Centene gained full control of Circle Health in July 2021, and sold the business to PureHealth in August 2023.
In early 2021, Operose Health, a UK subsidiary of Centene, took over a group of London practices, AT Medics.
In May 2022, Centene sold off its pharmacy benefit management businesses, Magellan Rx and PANTHERx Rare, for a total of $2.8 billion.
Business segments
The main lines of Centene include:
Medicaid
Arizona Complete Health
Arkansas Total Care
Health Net (California)
Delaware First Health
Sunshine Health (Florida)
Peach State Health Plan (Georgia)
'Ohana Health Plan (Hawaii)
Meridian (Illinois and Michigan)
Managed Health Care Services (Indiana)
Iowa Total Care
Sunflower Health Plan (Kansas)
WellCare of Kentucky
Louisiana Healthcare Connections
Magnolia Health (Mississippi)
Home State Health Plan (Missouri)
Nebraska Total Care
SilverSummit Healthplan (Nevada)
NH Healthy Families (New Hampshire)
Fidelis Care (New Jersey, New York)
Carolina Complete Health (North Carolina)
WellCare of North Carolina
Buckeye Health Plan (Ohio)
Oklahoma Complete Health
Trillium Community Health Plan (Oregon)
PA Health & Wellness (Pennsylvania)
Absolute Total Care (South Carolina)
Superior HealthPlan (Texas)
Coordinated Care (Washington)
MHS Health Wisconsin
ACA health insurance marketplace - Ambetter
Arkansas Health & Wellness
Celtic Insurance Company
WellCare of New Jersey
Medicare
WellCare
Allwell
Correctional healthcare - Centurion
Commercial insurance
QualChoice (Arkansas)
Health Net (California, Oregon)
Behavioral health - Magellan Health
Leaders
In 2020, CEO Michael Neidorff's compensation of nearly $25 million made him the highest-paid healthcare executive in the United States.
In December 2021, Politan Capital Management took a $900 million stake in Centene. Weeks later, Neidorff announced plans to retire within a year. He actually stepped down in March 2022.
He was replaced by Sarah London.
Controversies
In 2014, Fox News alleged that Superior HealthPlan of Texas denied coverage of an infant's surgery for brain cancer at Texas Children's Hospital. Superior HealthPlan is a joint venture of Centene and Community Health Centers Network LP, which provides services for Medicaid recipients. The article reported that Superior HealthPlan had previously paid healthcare claims for the infant at the hospital, although Superior HealthPlan stated that it did not cover procedures at the facility. Three days after the article was published, Superior HealthPlan reversed its decision and covered the surgery.
In January 2018, a class action lawsuit accused Centene's Ambetter marketplace healthcare plans of misleading enrollees about plan benefits. According to the lawsuit, people who bought Centene's plans had difficulty finding medical providers that accepted patients covered under Centene's policies.
In December 2018, Centene was sued by two pension funds alleging that Centene's acquisition of Health Net resulted in damages to Centene and exposed the company to potential liability. The suit also alleged that Centene concealed that Health Net owed approximately $1B in past tax liabilities to California and was under investigation for Medicare fraud at the time of the acquisition.
In 2022, Operose Health had almost 600,000 NHS patients and was the largest supplier of GP services to the NHS. It was accused of putting patients at risk by prioritising profit, specifically by hiring physician associates, because they were cheaper than GPs. At Operose practices the average number of full time equivalent GPs per patients is about half the average in English practices. Sir Sam Everington said he was worried to see physician associates saying they were not receiving the supervision they needed. The practice had a backlog of thousands of medical test results and hospital letters on their computer systems. Operose said 97% of its practices were rated "good" or "outstanding" by the Care Quality Commission.
In April of 2026, Centene Corporation reportedly ended coverage of hormone replacement therapy for transgender patients in its Ambetter Insurance medicare and medicaid plans across 19 states without informing customers.
Settlements
In April 2021, Health Net Federal Services, a subsidiary of Centene, agreed to pay $97M to settle allegations that it had duplicated or inflated claims submitted to the Department of Veterans Affairs.
Between June 2021 and January 2022, Centene agreed to settlements with several states on behalf of their subsidiary, Envolve, a pharmacy benefit manager, including Ohio, Mississippi, Illinois, Arkansas, and New Hampshire to resolve allegations of overpayments to the PBM from the states' Medicaid programs. The settlements have totaled over $191 million.
In December 2021, Centene agreed to pay $27.6M to Kansas to settle allegations that it had failed to disclose discounts and used other strategies to obtain more profit from Kansas' Medicaid program.
In September 2022, Centene will pay more than $14 million to Massachusetts's to resolve claims that it overcharged the state Medicaid program, MassHealth, millions of dollars for pharmacy benefits and services provided by subsidiary companies.
Centene overbilled Florida $67 million in 2021 and proactively notified the state. Their discussions with Agency for Health Care Administration (AHCA) ended in 2024 and Centene agreed to return the $67 million. $10 million of that was sent to Hope Florida Foundation, rather than the state directly.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
CNC 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
CNC 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
CNC 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 4 14.8%
- 매수 7 25.9%
- 보유 15 55.6%
- 매도 1 3.7%
- 적극 매도 0 0.0%
12개월 목표 주가
18 명의 애널리스트 · 2026-08-13실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $2.51 | $1.10 | 1.4% |
| 2026년 3월 31일 | $3.37 | $2.15 | 1.2% |
| 2025년 12월 31일 | $-1.19 | $-1.24 | 0.05% |
| 2025년 9월 30일 | $0.50 | $-0.14 | 0.64% |
| 2025년 6월 30일 | $-0.16 | $0.87 | -1.0% |
| 2025년 3월 31일 | $2.90 | $2.57 | 0.33% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | |
| Cost of Revenue | $2.67B | $2.73B | $3.56B | $7.03B | $4.89B | $3.30B | $2.46B | $2.39B | $1.85B | $1.86B | $1.62B | $1.28B | |
| Gross Profit | $14.21B | $17.07B | $17.64B | $16.92B | $14.49B | · | · | · | · | · | · | · | |
| SG&A Expense | $12.90B | $12.40B | $12.56B | $11.59B | $9.60B | $9.38B | $6.53B | $6.04B | $4.45B | $3.67B | $1.80B | $1.30B | |
| Operating Expenses | $202.40B | $159.90B | $151.07B | $143.23B | $124.20B | $108.03B | $72.86B | $58.66B | $47.18B | $39.34B | $22.05B | $16.10B | |
| Operating Income | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B | $705M | $464M | |
| Interest Expense | · | · | $725M | $665M | $665M | $728M | $412M | $343M | $255M | $217M | $43M | $35M | |
| Other Non-op | $895M | $1.08B | $668M | $644M | · | · | · | · | · | · | · | · | |
| Pretax Income | $-6.73B | $4.26B | $3.60B | $1.96B | $1.81B | $2.77B | $1.78B | $1.37B | $1.13B | $1.16B | $697M | $457M | |
| Income Tax | $-51M | $963M | $899M | $760M | $477M | $979M | $473M | $474M | $326M | $599M | $339M | $196M | |
| Net Income | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | |
| EPS (Basic) | $-13.53 | $6.33 | $4.97 | $2.09 | $2.31 | $3.17 | $3.19 | $2.31 | $2.40 | $1.76 | $2.98 | $2.33 | |
| EPS (Diluted) | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 | $3.12 | $3.14 | $2.26 | $2.34 | $1.71 | $2.88 | $2.25 | |
| Shares (Basic) | 493,116,000 | 521,790,000 | 543,319,000 | 575,191,000 | 582,832,000 | 570,722,000 | 413,487,000 | 390,248,000 | 344,853,000 | 319,135,000 | 119,101,000 | 116,345,764 | |
| Shares (Diluted) | 493,116,000 | 523,744,000 | 545,704,000 | 582,040,000 | 590,516,000 | 579,135,000 | 420,409,000 | 398,506,000 | 353,404,000 | 327,951,000 | 123,066,000 | 120,360,212 | |
| EBITDA | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B | $705M | $464M |
대차대조표 26
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17.89B | $14.06B | $17.19B | $12.07B | $13.12B | $10.80B | $12.12B | $5.34B | $4.07B | $3.93B | $1.76B | $1.61B | |
| Short-term Investments | $2.43B | $2.62B | $2.46B | $2.32B | $1.54B | $1.58B | $863M | $722M | $531M | $505M | $176M | $177M | |
| Other Current Assets | $1.95B | $1.60B | $5.57B | $2.46B | $1.60B | $1.32B | $1.09B | $784M | $687M | $715M | $390M | $252M | |
| Current Assets | $40.37B | $38.00B | $40.76B | $30.13B | $28.50B | $23.39B | $20.32B | $12.00B | $8.70B | $8.37B | $3.60B | $2.95B | |
| PP&E (Net) | $2.04B | $2.07B | $2.02B | $2.43B | $3.39B | $2.77B | $2.12B | $1.71B | $1.10B | $797M | $518M | $445M | |
| PP&E (Gross) | $4.27B | $4.87B | $4.42B | $4.50B | $5.29B | $4.25B | $3.22B | $2.51B | $1.69B | $1.24B | $869M | $733M | |
| Accum. Depreciation | $2.23B | $2.80B | $2.40B | $2.07B | $1.90B | $1.48B | $1.10B | $800M | $590M | $442M | $351M | $288M | |
| Goodwill | $10.84B | $17.56B | $17.56B | $18.81B | $19.77B | $18.65B | $6.86B | $7.01B | $4.75B | $4.71B | $842M | $754M | |
| Intangibles | $4.53B | $5.41B | $6.10B | $6.91B | $7.82B | $8.39B | $2.06B | $2.24B | $1.40B | $1.54B | $155M | $120M | |
| Other Non-current Assets | $528M | $593M | $535M | $2.69B | $3.78B | $1.60B | $1.25B | $527M | $454M | $95M | $177M | $174M | |
| Total Assets | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B | $7.34B | $5.82B | |
| Accounts Payable | $13.80B | $13.17B | $16.42B | $9.53B | $8.49B | $7.07B | $4.16B | $4.05B | $4.17B | $3.76B | $976M | $768M | |
| Current Liabilities | $36.72B | $34.26B | $36.72B | $28.46B | $25.77B | $21.59B | $12.93B | $11.97B | $9.33B | $8.62B | $3.63B | $2.90B | |
| Capital Leases | $615M | $738M | $880M | $3.13B | $3.62B | $1.33B | $622M | · | · | · | · | · | |
| Deferred Tax | $833M | $684M | $641M | $615M | $1.41B | $1.53B | $189M | · | · | · | · | · | |
| Other Non-current Liabilities | $1.79B | $2.57B | $3.62B | $5.62B | $5.61B | $2.96B | $1.54B | $1.26B | $952M | $869M | $170M | $159M | |
| Total Liabilities | $56.69B | $55.94B | $58.69B | $52.63B | $51.35B | $42.76B | $28.30B | $19.88B | $14.98B | $14.14B | $5.01B | $3.93B | |
| Long-term Debt | $17.49B | $18.64B | $17.96B | $18.18B | $19.03B | $16.88B | $13.86B | $6.85B | $4.83B | $4.78B | $1.22B | $878M | |
| Total Debt | $17.40B | $18.53B | $17.83B | $18.02B | $18.84B | $16.78B | $13.73B | $6.69B | $4.70B | $4.66B | $1.22B | $893M | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Retained Earnings | $8.67B | $15.35B | $12.04B | $9.34B | $8.14B | $6.79B | $4.98B | $3.66B | $2.75B | $1.92B | $1.36B | $1.00B | |
| Treasury Stock | $9.44B | $9.00B | $5.86B | $4.21B | $1.09B | $816M | $214M | $139M | $244M | $179M | $147M | $98M | |
| AOCI | $-58M | $-504M | $-652M | $-1.13B | $77M | $337M | $134M | $-56M | $-3M | $-36M | $-10M | $-1M | |
| Stockholders' Equity | $19.95B | $26.41B | $25.84B | $24.06B | $26.80B | $25.77B | $12.55B | $10.92B | $6.85B | $5.89B | $2.16B | $1.74B | |
| Liabilities + Equity | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B | $7.34B | $5.82B | |
| Shares Outstanding | 491,757,000 | 620,195,000 | 615,291,000 | 607,847,000 | 602,704,000 | 598,249,000 | 421,508,000 | 417,695,000 | 360,758,000 | 356,268,000 | 253,710,000 | 124,275,000 |
현금 흐름 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.27B | $1.24B | $1.29B | $1.43B | $1.33B | $1.26B | $643M | $495M | $361M | $278M | $111M | $89M | |
| Stock-based Comp | $204M | $212M | $216M | $234M | $203M | $281M | $177M | $145M | $135M | $148M | $71M | $48M | |
| Deferred Tax | $-60M | $13M | $-78M | $-631M | $-132M | $-51M | $55M | $-129M | $-108M | $92M | $-17M | $-42M | |
| Amort. of Intangibles | $685M | $692M | $718M | $817M | $770M | $719M | $258M | $211M | $156M | $147M | $24M | $16M | |
| Operating Cash Flow | $5.09B | $154M | $8.05B | $6.26B | $4.21B | $5.50B | $1.48B | $1.23B | $1.49B | $1.85B | $658M | $1.22B | |
| CapEx | $767M | $644M | $799M | $1.00B | $910M | $869M | $730M | $675M | $422M | $306M | $150M | $103M | |
| Investing Cash Flow | $472M | $-1.05B | $-1.19B | $-2.92B | $-3.30B | $-6.96B | $-1.53B | $-4.58B | $-1.25B | $-2.47B | $-813M | $-848M | |
| Debt Issued | $750M | $1.30B | $2.33B | $360M | $9.27B | $5.11B | $24.72B | $6.08B | $1.40B | $8.95B | $1.93B | $1.88B | |
| Net Debt Issued | $-1.15B | $678M | $19M | $-1.13B | $1.83B | $1.04B | $6.92B | $1.99B | $47M | $2.87B | $342M | $201M | |
| Stock Issued | $37M | $46M | $44M | $70M | $35M | $28M | $0 | $2.78B | $0 | $0 | · | · | |
| Stock Repurchased | $475M | $3.12B | $1.63B | $3.10B | $297M | $626M | $75M | $71M | $65M | $63M | $53M | $29M | |
| Net Stock Activity | $-438M | $-3.08B | $-1.59B | $-3.03B | $-297M | $-626M | $-75M | $2.71B | $-65M | $-63M | $-53M | $-29M | |
| Financing Cash Flow | $-1.62B | $-2.41B | $-1.66B | $-4.20B | $1.36B | $260M | $6.83B | $4.61B | $-82M | $2.72B | $305M | $198M | |
| Net Change in Cash | $3.94B | $-3.30B | $5.17B | $-868M | $2.26B | $-1.17B | $6.78B | $1.26B | $153M | $2.10B | $150M | $572M | |
| Taxes Paid | $448M | $1.00B | $887M | $1.20B | $678M | $1.19B | $612M | $448M | $496M | $556M | $328M | $237M | |
| Free Cash Flow | $4.32B | $-490M | $7.25B | $5.26B | $3.29B | $4.63B | $753M | $559M | $1.07B | $1.54B | $508M | $1.12B | |
| Levered FCF | · | · | $6.71B | $4.85B | $2.80B | $4.16B | $450M | $335M | $885M | $1.44B | $486M | $1.10B |
수익성 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.3% | 10.5% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% | 3.1% | 2.8% | |
| Net Margin | -3.4% | 2.0% | 1.8% | 0.83% | 1.1% | 1.6% | 1.8% | 1.5% | 1.7% | 1.4% | 1.6% | 1.6% | |
| Pretax Margin | -3.5% | 2.6% | 2.3% | 1.4% | 1.4% | 2.5% | 2.4% | 2.3% | 2.3% | 2.9% | 3.1% | 2.8% | |
| EBITDA Margin | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% | 3.1% | 2.8% | |
| ROA | -8.4% | 4.0% | 3.4% | 1.6% | 1.8% | 3.3% | 3.7% | 3.4% | 3.9% | 4.1% | 5.4% | 5.8% | |
| ROE | -28.8% | 12.7% | 10.8% | 4.7% | 5.1% | 9.4% | 11.3% | 10.1% | 13.0% | 14.0% | 18.2% | 18.2% | |
| ROIC | -20.2% | 5.5% | 5.0% | 1.9% | 2.9% | 4.7% | 5.0% | 5.4% | 7.4% | 5.8% | 10.7% | 10.1% |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.6 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Debt / Equity | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | |
| Interest Coverage | · | · | 4.0 | 2.0 | 2.7 | 4.2 | 4.3 | 4.3 | 4.7 | 5.8 | 16.4 | 13.3 |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.4 | 2.0 | 1.9 | 1.9 | 1.7 | 2.0 | 2.1 | 2.3 | 2.3 | 2.9 | 3.5 | 3.5 |
성장률 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.4% | 5.9% | 6.5% | 14.7% | 13.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 27.5% | 139.1% | -9.2% | -26.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 40.4% | 16.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 22.3% | 124.8% | -10.8% | -25.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 34.9% | 14.3% | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | |
| Net Income TTM | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | |
| Market Cap | $20.24B | $30.04B | $39.66B | $45.17B | $48.00B | $34.91B | $26.09B | $23.78B | $8.75B | $4.86B | $3.96B | $3.07B | |
| Enterprise Value | $17.32B | $31.89B | $37.84B | $48.79B | $52.18B | $39.31B | $26.83B | $24.40B | $8.84B | $5.08B | $3.24B | $2.24B | |
| P/E | -3.0 | 9.6 | 15.0 | 39.6 | 36.1 | 19.2 | 20.0 | 25.5 | 21.6 | 16.5 | 11.4 | 11.5 | |
| P/S | 0.1 | 0.2 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.4 | 0.2 | 0.1 | 0.2 | 0.2 | |
| P/B | 1.0 | 1.1 | 1.5 | 1.9 | 1.8 | 1.4 | 2.1 | 2.2 | 1.3 | 0.8 | 1.8 | 1.8 | |
| P / Tangible Book | 4.4 | 8.7 | 18.2 | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 4.0 | 195.1 | 4.9 | 7.2 | 11.4 | 6.3 | 17.6 | 19.3 | 5.9 | 2.6 | 6.0 | 2.5 | |
| P / FCF | 4.7 | -61.3 | 5.5 | 8.6 | 14.6 | 7.5 | 34.7 | 42.5 | 8.2 | 3.1 | 7.8 | 2.7 | |
| EV / EBITDA | -2.3 | 10.0 | 12.9 | 37.0 | 29.2 | 12.8 | 15.1 | 16.7 | 7.4 | 4.0 | 4.6 | 4.8 | |
| EV / FCF | 4.0 | -65.1 | 5.2 | 9.3 | 15.8 | 8.5 | 35.6 | 43.7 | 8.3 | 3.3 | 6.4 | 2.0 | |
| EV / Revenue | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Earnings Yield | -32.9% | 10.4% | 6.7% | 2.5% | 2.8% | 5.2% | 5.0% | 3.9% | 4.6% | 6.0% | 8.8% | 8.7% |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $53.58B | $49.94B | $49.73B | $49.69B | $48.74B | $46.62B | $40.80B | $42.02B | $39.84B | $40.41B | $39.46B | $38.04B | $37.61B | $38.89B | $35.56B | $35.87B | |
| Cost of Revenue | $729M | $702M | $680M | $651M | $641M | $698M | $688M | $692M | $680M | $669M | $961M | $856M | $877M | $870M | $1.37B | $1.57B | |
| Gross Profit | $4.62B | $5.65B | $2.56B | $3.35B | $3.02B | $5.29B | $3.80B | $4.01B | $4.53B | $4.74B | $3.74B | $4.63B | $4.61B | $4.65B | $3.91B | $4.04B | |
| SG&A Expense | $3.10B | $3.40B | $3.37B | $3.15B | $3.04B | $3.35B | $3.23B | $3.06B | $2.89B | $3.22B | $3.49B | $3.05B | $3.02B | $3.01B | $3.20B | $2.85B | |
| Operating Expenses | $52.38B | $48.08B | $51.47B | $56.64B | $49.20B | $45.09B | $40.63B | $41.36B | $38.61B | $39.30B | $39.65B | $37.31B | $36.44B | $37.67B | $35.84B | $35.39B | |
| Operating Income | $1.20B | $1.86B | $-1.75B | $-6.95B | $-458M | $1.53B | $175M | $665M | $1.23B | $1.11B | $-194M | $735M | $1.17B | $1.22B | $-282M | $476M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $178M | · | $181M | $181M | $180M | · | $169M | |
| Other Non-op | $288M | $238M | $202M | $280M | $201M | $212M | $172M | $256M | $287M | $367M | · | · | · | · | · | · | |
| Pretax Income | $1.49B | $2.10B | $-1.54B | $-6.67B | $-257M | $1.75B | $347M | $921M | $1.52B | $1.47B | $24M | $768M | $1.42B | $1.39B | $41M | $1.01B | |
| Income Tax | $399M | $560M | $-443M | $-42M | $2M | $432M | $67M | $211M | $370M | $315M | $-15M | $293M | $360M | $261M | $260M | $269M | |
| Net Income | $1.09B | $1.54B | $-1.10B | $-6.63B | $-253M | $1.31B | $283M | $713M | $1.15B | $1.16B | $45M | $469M | $1.06B | $1.13B | $-213M | $738M | |
| EPS (Basic) | $2.21 | $3.13 | $-2.16 | $-13.50 | $-0.51 | $2.64 | $0.63 | $1.37 | $2.16 | $2.17 | $0.12 | $0.87 | $1.93 | $2.05 | $-0.37 | $1.29 | |
| EPS (Diluted) | $2.19 | $3.11 | $-2.15 | $-13.50 | $-0.51 | $2.63 | $0.63 | $1.36 | $2.16 | $2.16 | $0.12 | $0.87 | $1.92 | $2.04 | $-0.35 | $1.27 | |
| Shares (Basic) | 493,819,000 | 492,069,000 | -987,787,000 | 491,141,000 | 493,548,000 | 496,214,000 | -1,064,886,000 | 521,965,000 | 529,602,000 | 535,109,000 | -1,095,927,000 | 539,535,000 | 548,932,000 | 550,779,000 | -1,165,644,000 | 573,961,000 | |
| Shares (Diluted) | 497,637,000 | 495,591,000 | -989,753,000 | 491,141,000 | 493,548,000 | 498,180,000 | -1,068,613,000 | 523,542,000 | 530,755,000 | 538,060,000 | -1,099,719,000 | 541,270,000 | 550,308,000 | 553,845,000 | -1,172,869,000 | 580,607,000 | |
| EBITDA | $1.20B | $1.86B | · | $-6.95B | $-458M | $1.53B | · | $665M | $1.23B | $1.11B | · | $735M | $1.17B | $1.22B | · | $476M |
대차대조표 26
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.15B | $21.26B | $17.89B | $17.06B | $14.51B | $14.81B | $14.06B | $14.58B | $17.61B | $17.59B | $17.19B | $18.19B | $17.17B | $15.85B | $12.07B | $14.99B | |
| Short-term Investments | $2.91B | $2.48B | $2.43B | $2.18B | $2.77B | $2.47B | $2.62B | $2.99B | $2.61B | $2.08B | · | $2.24B | $2.21B | $2.13B | · | $2.19B | |
| Other Current Assets | $1.55B | $1.82B | $1.95B | $1.72B | $1.56B | $1.56B | $1.60B | $1.56B | $1.60B | $1.96B | · | $5.47B | $1.88B | $1.81B | · | $2.33B | |
| Current Assets | $46.69B | $44.99B | $40.37B | $44.06B | $40.39B | $41.29B | $38.00B | $37.41B | $38.41B | $38.45B | · | $41.41B | $34.87B | $35.01B | · | $33.27B | |
| PP&E (Net) | $2.13B | $2.09B | $2.04B | $2.16B | $2.12B | $2.04B | $2.07B | $2.04B | $2.04B | $1.99B | · | $2.00B | $2.42B | $2.48B | · | $2.48B | |
| PP&E (Gross) | · | · | $4.27B | · | · | · | $4.87B | · | · | · | · | · | · | · | · | $4.54B | |
| Accum. Depreciation | · | · | $2.23B | · | · | · | $2.80B | · | · | · | · | · | · | · | · | $2.06B | |
| Goodwill | $10.84B | $10.84B | $10.84B | $10.84B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $18.72B | $18.84B | $18.81B | $20.04B | |
| Intangibles | $4.20B | $4.36B | $4.53B | $4.84B | $5.01B | $5.24B | $5.41B | $5.58B | $5.75B | $5.93B | · | $6.28B | $6.52B | $6.73B | · | $7.52B | |
| Other Non-current Assets | $1.37B | $866M | $528M | $593M | $1.11B | $1.24B | $593M | $617M | $1.09B | $823M | · | $560M | $2.87B | $2.78B | · | $2.60B | |
| Total Assets | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | · | $84.38B | $82.85B | $82.98B | · | $81.17B | |
| Accounts Payable | $17.96B | $16.83B | $13.77B | $16.88B | $13.52B | $13.95B | $13.17B | $13.34B | $12.23B | $12.13B | · | $15.08B | $9.87B | $10.78B | · | $9.99B | |
| Current Liabilities | $40.76B | $40.05B | $36.70B | $40.63B | $36.79B | $37.14B | $34.26B | $34.06B | $32.73B | $32.78B | · | $36.85B | $31.31B | $32.86B | · | $31.33B | |
| Capital Leases | · | · | $615M | · | · | · | $738M | · | · | · | · | $936M | $3.17B | $3.14B | · | $3.04B | |
| Deferred Tax | $756M | $744M | $833M | $810M | $651M | $708M | $684M | $769M | $665M | $734M | · | $577M | $495M | $522M | · | $480M | |
| Other Non-current Liabilities | $2.81B | $2.55B | $1.81B | $2.05B | $3.90B | $2.87B | $2.57B | $2.62B | $4.77B | $4.16B | · | $3.65B | $7.37B | $6.19B | · | $5.68B | |
| Total Liabilities | $60.35B | $59.65B | $56.69B | $61.03B | $58.89B | $59.02B | $55.94B | $54.94B | $55.68B | $55.56B | · | $58.97B | $57.07B | $57.80B | · | $55.57B | |
| Long-term Debt | $16.11B | $16.37B | $17.49B | $17.58B | $17.58B | $18.32B | $18.53B | $17.61B | $17.63B | $18.00B | · | $18.00B | $18.01B | $18.32B | · | $18.33B | |
| Total Debt | $16.11B | $16.37B | · | $17.58B | $17.58B | $18.32B | · | $17.61B | $17.63B | $18.00B | · | $18.00B | $18.01B | $18.32B | · | $18.33B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $11.31B | $10.21B | $8.67B | $9.78B | $16.41B | $16.66B | $15.35B | $15.06B | $14.35B | $13.21B | · | $12.00B | $11.53B | $10.47B | · | $9.55B | |
| Treasury Stock | $9.44B | $9.44B | $9.44B | $9.44B | $9.44B | $9.04B | $9.00B | $8.05B | $6.82B | $6.01B | · | $5.83B | $5.04B | $4.64B | · | $2.56B | |
| AOCI | $-194M | $-171M | $-58M | $-100M | $-231M | $-337M | $-504M | $-226M | $-646M | $-630M | · | $-1.12B | $-998M | $-915M | · | $-1.39B | |
| Stockholders' Equity | $22.56B | $21.43B | $19.95B | $20.95B | $27.41B | $27.92B | $26.41B | $27.31B | $27.35B | $26.96B | · | $25.30B | $25.67B | $25.04B | · | $25.38B | |
| Liabilities + Equity | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | · | $84.38B | $82.85B | $82.98B | · | $81.17B | |
| Shares Outstanding | 493,987,000 | 493,771,000 | 491,757,000 | 491,414,000 | 491,128,000 | 497,518,000 | 495,907,000 | 510,078,000 | 526,001,000 | 536,383,000 | 615,291,000 | 534,596,000 | 546,003,000 | 551,714,000 | 607,847,000 | 570,091,000 |
현금 흐름 17
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $300M | $300M | $329M | $317M | $315M | $314M | $314M | $313M | $306M | $308M | $315M | $328M | $304M | $325M | $351M | $292M | |
| Stock-based Comp | $59M | $67M | $58M | $52M | $35M | $59M | $31M | $49M | $62M | $70M | $49M | $50M | $56M | $61M | $54M | $51M | |
| Deferred Tax | $19M | $-53M | $-73M | $129M | $-89M | $-27M | $-1M | $-26M | $-64M | $104M | $-92M | $174M | $-1M | $-159M | $51M | $-265M | |
| Amort. of Intangibles | $161M | $166M | $169M | $170M | $173M | $173M | $173M | $173M | $173M | $173M | $176M | $180M | $179M | $183M | $208M | $211M | |
| Operating Cash Flow | $3.59B | $4.37B | $437M | $1.36B | $1.78B | $1.51B | $-587M | $-978M | $2.17B | $-456M | $217M | $1.02B | $2.55B | $4.27B | $-1.58B | $3.33B | |
| CapEx | $174M | $200M | $213M | $211M | $208M | $135M | $154M | $153M | $186M | $151M | $223M | $136M | $215M | $225M | $233M | $247M | |
| Investing Cash Flow | $-353M | $89M | $660M | $1.24B | $-899M | $-529M | $102M | $-839M | $-1.17B | $852M | $-949M | $435M | $-424M | $-253M | $221M | $3M | |
| Debt Issued | $0 | $0 | $0 | $0 | $0 | $750M | $950M | $0 | $0 | $350M | $165M | $889M | $994M | $287M | $3M | $26M | |
| Net Debt Issued | · | $-1.05B | · | · | · | $-208M | · | · | · | $163M | · | · | · | $287M | · | · | |
| Stock Issued | $8M | $10M | $8M | $11M | $8M | $10M | $9M | $12M | $11M | $14M | $12M | $11M | $21M | $12M | $8M | $24M | |
| Stock Repurchased | $4M | $29M | $2M | $0 | $432M | $41M | $943M | $1.23B | $803M | $151M | $31M | $774M | $405M | $423M | $1.43B | $1.24B | |
| Net Stock Activity | · | $-19M | · | · | · | $-31M | · | · | · | $-137M | · | · | · | $-423M | · | · | |
| Financing Cash Flow | $-259M | $-1.06B | $-187M | $-10M | $-1.17B | $-250M | $-13M | $-1.25B | $-1.17B | $23M | $-201M | $-524M | $-750M | $-183M | $-1.73B | $-1.48B | |
| Net Change in Cash | $2.98B | $3.39B | $910M | $2.59B | $-288M | $731M | $-497M | $-3.06B | $-162M | $425M | $-984M | $958M | $1.36B | $3.83B | $-3.06B | $1.83B | |
| Taxes Paid | $-206M | $-19M | $-92M | $36M | $497M | $7M | $181M | $211M | $538M | $13M | $128M | $167M | $581M | $11M | $750M | $37M | |
| Free Cash Flow | · | $4.17B | · | · | · | $1.38B | · | · | · | $-607M | · | · | · | $4.04B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-747M | · | · | · | $3.90B | · | · |
수익성 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.6% | 11.3% | · | 6.7% | 6.2% | 11.3% | · | 9.5% | 11.4% | 11.7% | · | 12.2% | 12.3% | 11.9% | · | · | |
| Operating Margin | 2.2% | 3.7% | · | -14.0% | -0.94% | 3.3% | · | 1.6% | 3.1% | 2.7% | · | 1.9% | 3.1% | 3.1% | · | 1.3% | |
| Net Margin | 2.0% | 3.1% | · | -13.3% | -0.52% | 2.8% | · | 1.7% | 2.9% | 2.9% | · | 1.2% | 2.8% | 2.9% | · | 2.1% | |
| Pretax Margin | 2.8% | 4.2% | · | -13.4% | -0.53% | 3.8% | · | 2.2% | 3.8% | 3.6% | · | 2.0% | 3.8% | 3.6% | · | 2.8% | |
| EBITDA Margin | 2.2% | 3.7% | · | -14.0% | -0.94% | 3.3% | · | 1.6% | 3.1% | 2.7% | · | 1.9% | 3.1% | 3.1% | · | 1.3% | |
| ROA | 1.3% | 1.8% | · | -8.1% | -0.30% | 1.6% | · | 0.86% | 1.4% | 1.4% | · | 0.57% | 1.3% | 1.4% | · | 0.93% | |
| ROE | 4.4% | 6.2% | · | -27.5% | -0.92% | 4.8% | · | 2.7% | 4.3% | 4.5% | · | 1.8% | 4.1% | 4.3% | · | 2.9% | |
| ROIC | 2.3% | 3.6% | · | -17.9% | -1.0% | 2.5% | · | 1.1% | 2.1% | 1.9% | · | 1.1% | 2.0% | 2.3% | · | 0.80% |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | |
| Quick Ratio | 0.7 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| Debt / Equity | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 6.2 | · | 4.1 | 6.5 | 6.8 | · | 2.8 |
효율성 1
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 |
가치 평가 (TTM) 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $201.96B | $195.00B | · | $187.07B | $177.22B | $168.89B | · | $160.31B | $155.89B | $154.95B | · | $150.40B | $148.30B | $147.88B | · | $141.39B | |
| Net Income TTM | $-4.25B | $-4.03B | · | $-4.86B | $2.92B | $4.33B | · | $3.49B | $3.84B | $3.82B | · | $3.40B | $2.75B | $2.54B | · | $2.00B | |
| Market Cap | $31.71B | $16.17B | · | $17.53B | $26.66B | $30.20B | · | $38.40B | $34.87B | $42.10B | · | $36.82B | $36.83B | $34.87B | · | $44.36B | |
| Enterprise Value | $20.76B | $8.80B | · | $15.88B | $26.95B | $31.24B | · | $38.43B | $32.29B | $40.43B | · | $34.39B | $35.45B | $35.21B | · | $45.51B | |
| P/E | -7.4 | -4.0 | · | -3.6 | 9.6 | 7.3 | · | 11.5 | 9.3 | 11.2 | · | 11.3 | 13.7 | 14.2 | · | 22.8 | |
| P/S | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| P/B | 1.4 | 0.8 | · | 0.8 | 1.0 | 1.1 | · | 1.4 | 1.3 | 1.6 | · | 1.5 | 1.4 | 1.4 | · | 1.7 | |
| P / Tangible Book | 4.2 | 2.6 | · | 3.3 | 5.5 | 5.9 | · | 9.2 | 8.6 | 12.1 | · | 25.2 | 84.7 | · | · | · | |
| P / Cash Flow | · | 3.7 | · | · | · | 20.0 | · | · | · | -92.3 | · | · | · | 8.2 | · | · | |
| P / FCF | · | 3.9 | · | · | · | 22.0 | · | · | · | -69.3 | · | · | · | 8.6 | · | · | |
| EV / EBITDA | 17.3 | 4.7 | · | -2.3 | -58.9 | 20.4 | · | 57.8 | 26.3 | 36.6 | · | 46.8 | 30.3 | 28.9 | · | 95.6 | |
| EV / FCF | · | 2.1 | · | · | · | 22.7 | · | · | · | -66.6 | · | · | · | 8.7 | · | · | |
| EV / Revenue | 0.1 | 0.0 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Earnings Yield | -13.6% | -25.3% | · | -28.1% | 10.4% | 13.7% | · | 8.7% | 10.7% | 8.9% | · | 8.9% | 7.3% | 7.1% | · | 4.4% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B |
| 매출 총이익률 % | 7.3% | 10.5% | 11.5% | — | — |
| 영업이익률 % | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% |
| 순이익 | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B |
| 희석 EPS | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 |
| 유동비율 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| 당좌 비율 | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $4.32B | $-490M | $7.25B | $5.26B | $3.29B |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 1,120개의 제출자 · $20.6B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 235 (+120 이전 분기 대비) | 74 (-55 이전 분기 대비) | 345 (+50 이전 분기 대비) | 323 (-35 이전 분기 대비) | +79.5M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2,020,581,807 | 31,478,140 | 9.81% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,434,820,070 | 22,352,704 | 6.96% | 주식 |
| STATE STREET CORP | $1,409,957,100 | 21,965,370 | 6.84% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $836,741,748 | 13,035,391 | 4.06% | 주식 |
| AMERIPRISE FINANCIAL INC | $788,928,731 | 12,277,112 | 3.83% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $754,901,345 | 11,765,825 | 3.66% | 주식 |
| HARRIS ASSOCIATES L P | $714,090,642 | 11,124,640 | 3.47% | 주식 |
| NORGES BANK | $491,166,346 | 7,651,758 | 2.38% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $478,360,377 | 7,452,257 | 2.32% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $407,480,559 | 6,348,038 | 1.98% | 주식 |
| VICTORY CAPITAL MANAGEMENT INC | $366,680,625 | 5,712,426 | 1.78% | 주식 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $314,595,190 | 4,901,000 | 1.53% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $290,158,057 | 4,520,300 | 1.41% | 콜 옵션 |
| Assenagon Asset Management S.A. | $238,531,902 | 3,716,029 | 1.16% | 주식 |
| EARNEST PARTNERS LLC | $227,030,787 | 3,536,856 | 1.10% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $219,279,973 | 3,416,108 | 1.06% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $197,821,063 | 3,081,805 | 0.96% | 주식 |
| 8 KNOTS MANAGEMENT, LLC | $193,662,188 | 4,706,250 | 0.94% | 주식 |
| Robeco Institutional Asset Management B.V. | $176,439,634 | 2,748,709 | 0.86% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $170,815,325 | 2,661,089 | 0.83% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $170,810,874 | 2,661,020 | 0.83% | 주식 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $164,395,918 | 2,561,083 | 0.80% | 주식 |
| JANE STREET GROUP, LLC | $161,149,958 | 2,510,515 | 0.78% | 주식 |
| LYRICAL ASSET MANAGEMENT LP | $157,262,740 | 2,449,957 | 0.76% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $156,896,112 | 2,444,246 | 0.76% | 주식 |
| JANE STREET GROUP, LLC | $150,243,114 | 2,340,600 | 0.73% | 콜 옵션 |
| RENAISSANCE TECHNOLOGIES LLC | $140,730,926 | 2,192,412 | 0.68% | 주식 |
| Politan Capital Management LP | $137,059,130 | 2,135,210 | 0.67% | 주식 |
| CITADEL ADVISORS LLC | $135,787,526 | 2,115,400 | 0.66% | 콜 옵션 |
| Qube Research & Technologies Ltd | $131,408,741 | 2,047,184 | 0.64% | 주식 |
| Quantinno Capital Management LP | $126,343,727 | 1,968,277 | 0.61% | 주식 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $121,065,870 | 1,886,055 | 0.59% | 주식 |
| Scharf Investments, LLC | $105,948,709 | 1,650,542 | 0.51% | 주식 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $104,240,580 | 1,623,938 | 0.51% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $102,119,807 | 1,590,899 | 0.50% | 주식 |
| Ninety One UK Ltd | $97,040,208 | 1,511,766 | 0.47% | 주식 |
| BlackRock, Inc. | $96,995,070 | 1,511,062 | 0.47% | 주식 |
| IEQ CAPITAL, LLC | $94,667,113 | 1,474,796 | 0.46% | 주식 |
| Long Focus Capital Management, LLC | $93,075,500 | 1,450,000 | 0.45% | 주식 |
| Caisse de depot et placement du Quebec | $90,440,436 | 1,408,949 | 0.44% | 주식 |
| TWO SIGMA ADVISERS, LP | $90,393,876 | 2,196,692 | 0.44% | 주식 |
| Walleye Trading LLC | $89,769,715 | 1,398,500 | 0.44% | 콜 옵션 |
| Swiss National Bank | $89,039,490 | 1,387,124 | 0.43% | 주식 |
| Maple Rock Capital Partners Inc. | $88,702,813 | 1,381,879 | 0.43% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $88,037,805 | 1,371,519 | 0.43% | 주식 |
| Capital World Investors | $85,968,319 | 1,339,279 | 0.42% | 주식 |
| ROYAL BANK OF CANADA | $83,731,000 | 1,304,424 | 0.41% | 주식 |
| FMR LLC | $82,642,699 | 1,287,470 | 0.40% | 주식 |
| Legal & General Group Plc | $82,580,180 | 1,286,496 | 0.40% | 주식 |
| GOLDMAN SACHS GROUP INC | $81,658,346 | 1,272,135 | 0.40% | 주식 |
| Swedbank AB | $81,278,855 | 1,266,223 | 0.39% | 주식 |
| BANK OF AMERICA CORP /DE/ | $81,231,546 | 1,265,486 | 0.39% | 주식 |
| BANK OF MONTREAL /CAN/ | $75,731,362 | 1,179,800 | 0.37% | 풋 옵션 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $74,883,027 | 1,166,584 | 0.36% | 주식 |
| Focused Investors LLC | $71,748,372 | 1,117,750 | 0.35% | 주식 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $69,539,402 | 1,083,337 | 0.34% | 주식 |
| Sumitomo Mitsui Trust Group, Inc. | $69,328,795 | 1,080,056 | 0.34% | 주식 |
| Vanguard Global Advisers, LLC | $67,731,876 | 1,055,178 | 0.33% | 주식 |
| CAXTON ASSOCIATES LP | $66,708,455 | 1,101,163 | 0.32% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $65,768,946 | 1,024,598 | 0.32% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65,005,213 | 1,012,700 | 0.32% | 풋 옵션 |
| RHUMBLINE ADVISERS | $64,689,517 | 1,007,784 | 0.31% | 주식 |
| Korea Investment CORP | $64,394,509 | 1,003,186 | 0.31% | 주식 |
| Walleye Trading LLC | $63,084,520 | 982,778 | 0.31% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $61,600,511 | 959,659 | 0.30% | 주식 |
| National Pension Service | $60,317,674 | 939,674 | 0.29% | 주식 |
| JANE STREET GROUP, LLC | $58,470,671 | 910,900 | 0.28% | 풋 옵션 |
| CITADEL ADVISORS LLC | $57,584,849 | 897,100 | 0.28% | 풋 옵션 |
| Vinva Investment Management Ltd | $57,411,190 | 885,450 | 0.28% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $54,527,351 | 849,468 | 0.26% | 주식 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $53,459,229 | 832,828 | 0.26% | 주식 |
| BANK OF NOVA SCOTIA | $53,046,262 | 826,395 | 0.26% | 주식 |
| California Public Employees Retirement System | $52,789,535 | 822,395 | 0.26% | 주식 |
| Gotham Asset Management, LLC | $51,174,579 | 797,236 | 0.25% | 주식 |
| Pine Valley Investments Ltd Liability Co | $49,047,579 | 764,100 | 0.24% | 주식 |
| ENVESTNET ASSET MANAGEMENT INC | $48,416,284 | 754,265 | 0.23% | 주식 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $46,947,683 | 730,827 | 0.23% | 주식 |
| Cresset Asset Management, LLC | $46,069,740 | 717,709 | 0.22% | 주식 |
| Walleye Trading LLC | $45,581,319 | 710,100 | 0.22% | 풋 옵션 |
| PRUDENTIAL FINANCIAL INC | $44,480,846 | 692,956 | 0.22% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $44,054,239 | 686,310 | 0.21% | 주식 |
| Point72 Asset Management, L.P. | $43,807,685 | 682,469 | 0.21% | 주식 |
| CAMBIAR INVESTORS LLC | $43,472,742 | 677,251 | 0.21% | 주식 |
| Kopernik Global Investors, LLC | $41,512,700 | 646,716 | 0.20% | 주식 |
| D. E. Shaw & Co., Inc. | $41,248,494 | 642,600 | 0.20% | 풋 옵션 |
| BARCLAYS PLC | $40,106,039 | 624,802 | 0.19% | 주식 |
| Alberta Investment Management Corp | $38,514,000 | 600,000 | 0.19% | 주식 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $37,494,278 | 584,114 | 0.18% | 주식 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $37,459,914 | 618,349 | 0.18% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $36,941,345 | 575,500 | 0.18% | 콜 옵션 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $36,392,328 | 566,947 | 0.18% | 주식 |
| Pictet Asset Management Holding SA | $35,261,300 | 549,327 | 0.17% | 주식 |
| PRINCIPAL FINANCIAL GROUP INC | $33,902,270 | 528,155 | 0.16% | 주식 |
| VANGUARD GROUP INC | $33,224,057 | 807,389 | 0.16% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $30,879,877 | 943,185 | 0.15% | 주식 |
| MACKENZIE FINANCIAL CORP | $30,726,084 | 478,674 | 0.15% | 주식 |
| IMC-Chicago, LLC | $30,548,920 | 475,914 | 0.15% | 주식 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $30,455,395 | 474,457 | 0.15% | 주식 |
| Polar Capital Holdings Plc | $30,274,251 | 471,635 | 0.15% | 주식 |
| JONES FINANCIAL COMPANIES LLLP | $29,598,153 | 450,299 | 0.14% | 주식 |
회사 내부자 77 명의 내부자 · 48 임원 · 30 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Sarah London | Chief Executive Officer | 2026년 3월 15일 F | 1,188,831 | 0 | 0 | $0 |
| David P Thomas | CEO, Markets and Medicaid | 2023년 12월 15일 F | 132,941 | 0 | 0 | $0 |
| NEIDORFF MICHAEL F | Chairman & CEO | 2021년 12월 15일 A | 6,517,610 | 0 | 0 | $0 |
| Andrew Lynn Asher | Chief Financial Officer | 2026년 3월 15일 F | 747,989 | 0 | 0 | $0 |
| William Scheffel | Exec VP, CFO & Treasurer | 2016년 3월 1일 F | 138,362 | 0 | 0 | $0 |
| Michael A Carson | Group President, Medicare&Spec | 2026년 5월 29일 I | — | 0 | 0 | $0 |
| Kenneth J Fasola | President | 2024년 7월 4일 F | 286,066 | 0 | 0 | $0 |
| Susan Raye Smith | Chief Operating Officer | 2026년 6월 15일 F | 212,237 | 0 | 0 | $0 |
| James E Murray | EVP, Chief Operating Officer | 2023년 6월 23일 A | 202,853 | 0 | 0 | $0 |
| Tanya M Mcnally | Chief People Officer | 2026년 4월 15일 F | 127,258 | 0 | 0 | $0 |
| Katie Casso | Corporate Controller & CAO | 2026년 3월 15일 F | 109,776 | 0 | 0 | $0 |
| Christopher Koster | Secretary & General Counsel | 2026년 3월 15일 F | 352,836 | 0 | 0 | $0 |
| Colin A Toney | EVP, Mergers & Acquisitions | 2022년 9월 16일 A | 52,123 | 0 | 0 | $0 |
| Mark J Brooks | EVP, Chief Information Officer | 2022년 9월 16일 A | 153,755 | 0 | 0 | $0 |
| Shannon Bagley | EVP, Chief Admin. Officer | 2022년 8월 16일 F | 116,705 | 0 | 0 | $0 |
| Brandy Burkhalter | EVP | 2022년 3월 24일 F | 350,475 | 0 | 0 | $0 |
| Jesse N Hunter | EVP, M&A & Chief Strategy Ofcr | 2021년 6월 11일 S | 411,792 | 0 | 0 | $0 |
| Jeffrey A. Schwaneke | EVP, HealthCare Enterprises | 2021년 5월 7일 S | 454,549 | 0 | 0 | $0 |
| Christopher R Isaak | SVP, Corporate Controller, CAO | 2020년 12월 15일 F | 13,630 | 0 | 0 | $0 |
| Keith H Williamson | EVP, Secr. & General Counsel | 2020년 2월 4일 F | 174,049 | 0 | 0 | $0 |
| Christopher D Bowers | EVP, Markets | 2019년 7월 22일 A | 131,492 | 0 | 0 | $0 |
| Cynthia J Brinkley | EVP, Chief Admin/Markets Offcr | 2019년 2월 5일 F | 300,582 | 0 | 0 | $0 |
| Kenneth Rone Baldwin | EVP, Markets | 2016년 12월 15일 F | 92,712 | 0 | 0 | $0 |
| Carol Goldman | Exec VP Chief Admin Officer | 2016년 12월 15일 F | 70,876 | 0 | 0 | $0 |
| Donald G Imholz | EVP, Operations and CIO | 2015년 12월 11일 G | 151,599 | 0 | 0 | $0 |
| David C Minifie | CMO, EVP Corporate Strategy | 2015년 2월 3일 F | 24,031 | 0 | 0 | $0 |
| Robert T Hitchcock | EVP Health Plans | 2015년 2월 3일 F | 26,415 | 0 | 0 | $0 |
| Edmund E Kroll | SVP Fin & Investor Relations | 2015년 2월 3일 F | 46,279 | 0 | 0 | $0 |
| HARROLD JASON M | EVP, Specialty Comp. Bus. Unit | 2015년 2월 3일 F | 44,329 | 0 | 0 | $0 |
| Karen Bedell | SVP Business Liaison | 2012년 12월 14일 F | 46,819 | 0 | 0 | $0 |
| Mary V Mason | SVP & Chief Medical Officer | 2012년 12월 14일 F | 38,974 | 0 | 0 | $0 |
| Mark W Eggert | Executive VP, Health Plans | 2012년 2월 14일 M | 103,712 | 0 | 0 | $0 |
| Antonette Simonetti | SVP, Public Affairs | 2010년 12월 14일 F | 13,377 | 0 | 0 | $0 |
| Frederick J Manning | Executive Vice President | 2010년 12월 14일 F | 20,579 | 0 | 0 | $0 |
| Cary Hobbs | SVP, Bus Mgmt & Integration | 2009년 12월 16일 M | 20,768 | 0 | 0 | $0 |
| Eric Slusser | Executive VP of Internat'l Dev | 2009년 10월 16일 A | 51,754 | 0 | 0 | $0 |
| Patti Darnley | Sr. VP of Operations | 2007년 12월 14일 A | 14,188 | 0 | 0 | $0 |
| Marie J Glancy | SVP, Oper Svcs & Reg Affairs | 2007년 12월 14일 A | 12,362 | 0 | 0 | $0 |
| Per J Brodin | SVP, Chief Acctg Officer | 2007년 12월 12일 A | 13,337 | 0 | 0 | $0 |
| Glendon A Schuster | Senior VP and CIO | 2006년 12월 12일 A | — | 0 | 0 | $0 |
| Lisa M Wilson | Sr. VP Investor Relations | 2006년 12월 12일 A | 18,400 | 0 | 0 | $0 |
| Karey L Witty | SVP, Health Plan Business Unit | 2006년 12월 12일 A | 57,500 | 0 | 0 | $0 |
| Joseph P Drozda JR | Sr. VP & Chief Medical Officer | 2006년 12월 12일 A | 32,181 | 0 | 0 | $0 |
| James D Donovan JR | Senior VP Health Plans | 2005년 12월 13일 A | 3,219 | 0 | 0 | $0 |
| Brian G Spanel | Sr Vice President, Development | 2005년 6월 24일 M | 186,446 | 0 | 0 | $0 |
| Dan Paquin | Sr. VP New Plan Implementation | 2005년 2월 10일 M | 0 | 0 | 0 | $0 |
| John Tadich | Senior VP, Specialty Companies | 2004년 12월 1일 M | 0 | 0 | 0 | $0 |
| Catherine M Halverson | Senior VP Business Development | 2004년 1월 16일 | 0 | 0 | 0 | $0 |
| Paul J Diaz | 이사 | 2026년 7월 28일 A | 2,771 | 0 | 0 | $0 |
| Lauren M Tyler | 이사 | 2026년 7월 17일 A | 3,216 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
ETF 보유 현황 186 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| IHF · iShares Trust | 4.19% | 807,594 SH | 2026년 8월 8일 | 일간 |
| CAMX · ADVISORS' INNER CIRCLE FUND | 3.57% | 44,000 NS | 2026년 4월 30일 | N-PORT |
| SMRI · EA Series Trust | 3.05% | 307,327 NS | 2026년 4월 30일 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2.65% | 686,794 SH | 2026년 8월 8일 | 일간 |
| SRHQ · Elevation Series Trust | 1.96% | 70,588 NS | 2026년 4월 30일 | N-PORT |
| GKAT · Advisors Series Trust | 1.93% | 87,905 NS | 2026년 3월 31일 | N-PORT |
| RUNN · Strategic Trust | 1.87% | 108,380 NS | 2026년 5월 31일 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1.82% | 68,233 SH | 2026년 8월 8일 | 일간 |
| KAT · Advisors Series Trust | 1.68% | 345,595 NS | 2026년 3월 31일 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.52% | 181,368 SH | 2026년 8월 8일 | 일간 |
| EPMB · Harbor ETF Trust | 1.51% | 1,264 NS | 2026년 4월 30일 | N-PORT |
| EPMV · Harbor ETF Trust | 1.40% | 1,157 NS | 2026년 4월 30일 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1.32% | 2,739 NS | 2026년 4월 30일 | N-PORT |
| EPSB · Harbor ETF Trust | 1.29% | 1,122 NS | 2026년 4월 30일 | N-PORT |
| ABCS · EA Series Trust | 1.12% | 2,127 NS | 2026년 5월 29일 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 1.04% | 30,046,000 | 2026년 8월 8일 | 일간 |
| AVMV · AMERICAN CENTURY ETF TRUST | 1.01% | 105,126 NS | 2026년 5월 31일 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.97% | 1,475,110 SH | 2026년 8월 8일 | 일간 |
| RILA · Spinnaker ETF Series | 0.92% | 7,203 NS | 2026년 4월 30일 | N-PORT |
| SPXD · DBX ETF Trust | 0.75% | 856 NS | 2026년 5월 31일 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.75% | 22,285,000 | 2026년 8월 8일 | 일간 |
| WLDR · Two Roads Shared Trust | 0.74% | 9,894 NS | 2026년 4월 30일 | N-PORT |
| ITAN · EA Series Trust | 0.66% | 9,949 NS | 2026년 5월 29일 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0.65% | 149,910 SH | 2026년 8월 8일 | 일간 |
| CLSE · Trust for Professional Managers | 0.64% | 66,218 NS | 2026년 5월 31일 | N-PORT |
| INFO · Harbor ETF Trust | 0.63% | 90,872 NS | 2026년 4월 30일 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0.62% | 139,637 NS | 2026년 4월 30일 | N-PORT |
| QIDX · Spinnaker ETF Series | 0.53% | 3,779 NS | 2026년 4월 30일 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.52% | 1,263,251 NS | 2026년 5월 31일 | N-PORT |
| IYH · iShares Trust | 0.51% | 295,112 SH | 2026년 8월 8일 | 일간 |
| VLUE · iShares Trust | 0.51% | 742,494 SH | 2026년 8월 8일 | 일간 |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.48% | 18,134,000 | 2026년 8월 8일 | 일간 |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0.48% | 1,515,000 PA | 2026년 8월 8일 | 일간 |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.48% | 819 NS | 2026년 5월 31일 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.47% | 1,478,248 SH | 2026년 8월 8일 | 일간 |
| AVLV · AMERICAN CENTURY ETF TRUST | 0.44% | 942,740 NS | 2026년 5월 31일 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.43% | 62,007 SH | 2026년 8월 8일 | 일간 |
| FHLC · FIDELITY COVINGTON TRUST | 0.43% | 226,652 NS | 2026년 4월 30일 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0.43% | 1,819,403 NS | 2026년 5월 31일 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0.41% | 173,542 NS | 2026년 4월 30일 | N-PORT |
| RXL · ProShares Trust | 0.40% | 4,871 NS | 2026년 5월 31일 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.40% | 611,391 SH | 2026년 8월 8일 | 일간 |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.40% | 27,252 NS | 2026년 5월 31일 | N-PORT |
| REVS · Columbia ETF Trust I | 0.40% | 21,013 NS | 2026년 4월 30일 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.39% | 85,952 NS | 2026년 5월 31일 | N-PORT |
| ESMV · iShares Trust | 0.38% | 471 SH | 2026년 8월 8일 | 일간 |
| CGGO · Capital Group Global Growth Equity … | 0.38% | 728,871 NS | 2026년 5월 31일 | N-PORT |
| IXJ · iShares Trust | 0.38% | 246,114 SH | 2026년 8월 8일 | 일간 |
| COPY · RBB Fund Trust | 0.36% | 21,043 NS | 2026년 5월 31일 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.36% | 9,315 NS | 2026년 4월 30일 | N-PORT |